Significant research funding in the form of a five-year, $12.1 million U19 Grant from the National Institutes of Health (NIH) has been awarded to a collaboration of research teams co-led by ...
The impact of adverse financial events on healthcare utilization and treatment costs at the end of life. Guideline-concordant use of olanzapine as part of a 4-drug antiemetic regimen for high emetic ...
Core Director: Rui-Ming Liu, Ph.D. Idiopathic pulmonary fibrosis (IPF) is a most enigmatic fatal lung disorder. Although significant progress has been made in our understanding of IPF pathogenesis, ...
Public Health Relevance Statement: Idiopathic Pulmonary Fibrosis (IPF) is fatal lung disorder for which no U.S. FDA-approved drugs currently exist. This project will lead to the development of novel ...
This project is not being offered for the current term. Please check back next semester for updates. The research of our laboratory is focused on lung embryonic specification and especially lung ...
Renovaro Inc. announces funding approval for LUMINA, a platform detecting minimal residual disease in lung cancer using multi-omics and AI. Renovaro Inc. announced that its subsidiary, RenovaroCube, ...
Please provide your email address to receive an email when new articles are posted on . Next-generation technologies and diagnostic tests offer the promise of improved cancer care, but they also ...
This project is not being offered for the current term. Please check back next semester for updates. Cancer cells have altered metabolism and consume significantly more glucose than normal cells, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results